Patents by Inventor David Driver

David Driver has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20050246716
    Abstract: An application program interface (API) provides a set of functions, including a set of base classes and types that are used in substantially all applications accessing the API, for application developers who build Web applications on Microsoft Corporation's .NETâ„¢ platform.
    Type: Application
    Filed: June 23, 2005
    Publication date: November 3, 2005
    Applicant: Microsoft Corporation
    Inventors: Adam Smith, Anthony Moore, Brian LaMacchia, Anders Hejlsberg, Brian Grunkemeyer, Caleb Doise, Christopher Brumme, Christopher Anderson, Corina Feuerstein, Craig Sinclair, Daniel Takacs, David Ebbo, David Driver, David Mortenson, Erik Christensen, Erik Olson, Fabio Yeon, Gopala Kakivaya, Gregory Fee, Hany Ramadan, Henry Sanders, Jayanth Rajan, Jeffrey Cooperstein, Jonathan Hawkins, James Hogg, Joe Long, John McConnell, Jesus Ruiz-Scougall, James Miller, Julie Bennett, Krzysztof Cwalina, Lance Olson, Loren Kohnfelder, Michael Magruder, Manish Prabhu, Radu Palanca, Raja Krishnaswamy, Shawn Burke, Sean Trowbridge, Seth Demsey, Shajan Dasan, Stefan Pharies, Suzanne Cook, Tarun Anand, Travis Muhlestein, Yann Christensen, Yung-shin Lin, Ramasamy Krishnaswamy, Joseph Roxe, Alan Boshier, David Bau
  • Publication number: 20050240943
    Abstract: An application program interface (API) provides a set of functions, including a set of base classes and types that are used in substantially all applications accessing the API, for application developers who build Web applications on Microsoft Corporation's .NETâ„¢ platform.
    Type: Application
    Filed: June 23, 2005
    Publication date: October 27, 2005
    Applicant: Microsoft Corporation
    Inventors: Adam Smith, Anthony Moore, Brian LaMacchia, Anders Hejlsberg, Biran Grunkemeyer, Caleb Doise, Christopher Brumme, Christopher Anderson, Corina Feuerstein, Craig Sinclair, Daniel Takacs, David Ebbo, David Driver, David Mortenson, Erik Christensen, Erik Olson, Fabio Yeon, Gopala Kakivaya, George Fee, Hany Ramadan, Henry Sanders, Jayanth Rajan, Jeffrey Cooperstein, Jonathan Hawkins, James Hogg, Joe Long, John McConnell, Jesus Ruiz-Scougall, James Miller, Julie Bennett, Krzysztof Cwalina, Lance Olson, Loren Kohnfelder, Michael Magruder, Manish Prabhu, Radu Palanca, Raja Krishnaswamy, Shawn Burke, Sean Trowbridge, Seth Demsey, Shajan Dasan, Stefan Pharies, Suzanne Cook, Tarun Anand, Travis Muhlestein, Yann Christensen, Yung-shin Lin, Ramasamy Krishnaswamy, Joseph Roxe, Alan Boshier, David Bau
  • Publication number: 20050026161
    Abstract: The present invention is directed to labeling antibodies with DNA in a convenient kit format for the purpose of producing and utilizing nucleic acid detection immunoassays. The process comprises treating a reporter antibody with a chemically activated strand of DNA, which serves as a template for any DNA amplification system. The reporter antibody-DNA conjugate is used to form a complex with corresponding antigen. The complex can be detected by the production of multiple copies of the DNA template. The kit may also provide an activated DNA sequence to label a capture antibody. The DNA conjugated to the capture antibody is modified to contain a high affinity binding ligand for the purpose of coating a solid support. The coated solid support functions to capture the immune complex containing reporter antibody in a sandwich assay format. The DNA sequence of the capture antibody may also have properties providing for the detachment of the complex from the solid support.
    Type: Application
    Filed: November 3, 2003
    Publication date: February 3, 2005
    Inventors: Edward Jablonski, David Driver, Thomas Adams
  • Publication number: 20040029278
    Abstract: The present invention provides compositions and methods for utilizing recombinant alphavirus vectors. Also disclosed are compositions and methods for making and utilizing eukaryotic layered vector initiation systems.
    Type: Application
    Filed: May 17, 2002
    Publication date: February 12, 2004
    Applicant: Chiron Corporation
    Inventors: Thomas W. Dubensky, John M. Polo, Carlos E. Ibanez, Stephen M.W. Chang, Douglas J. Jolly, David A. Driver, Barbara A. Belli
  • Publication number: 20030232035
    Abstract: The present invention provides compositions and methods for utilizing recombinant alphavirus vectors. Also disclosed are compositions and methods for making and utilizing eukaryotic layered vector initiation systems.
    Type: Application
    Filed: January 16, 2003
    Publication date: December 18, 2003
    Inventors: Thomas W. Dubensky, John M. Polo, Carlos E. Ibanez, Stephen M.W. Chang, Douglas J. Jolly, David A. Driver, Barbara A. Belli
  • Patent number: 6376236
    Abstract: Disclosed are recombinant alphavirus particles comprising a) an alphavirus vector construct which directs the expression of a heterologous nucleic acid molecule; b) a capsid protein; and c) an envelope glycoprotein from a virus different from said alphavirus vector.
    Type: Grant
    Filed: January 22, 1999
    Date of Patent: April 23, 2002
    Assignee: Chiron Corporation
    Inventors: Thomas W. Dubensky, Jr., John M. Polo, Carlos E. Ibanez, David A. Driver
  • Patent number: 6342372
    Abstract: The present invention provides compositions and methods for utilizing recombinant alphavirus vectors. Also disclosed are compositions and methods for making and utilizing eukaryotic layered vector initiation systems.
    Type: Grant
    Filed: July 8, 1999
    Date of Patent: January 29, 2002
    Assignee: Chiron Corporation
    Inventors: Thomas W. Dubensky, Jr., John M. Polo, David A. Driver
  • Patent number: 6333195
    Abstract: Retroviral vector constructs are described which have a 5′ LTR, a tRNA binding site, a packaging signal, one or more heterologous sequences, an origin of second strand synthesis and a 3′ LTR, wherein the vector construct lacks retroviral gag/pol or env coding sequences. In addition, gag/pol, and env expression cassettes are described wherein the expression cassettes lack a consecutive sequence of more than 8 nucleotides in common. The above-described retroviral vector constructs, gag/pol and env expression cassettes may be utilized to construct producer cell lines which preclude the formation of replication competent virus.
    Type: Grant
    Filed: January 7, 2000
    Date of Patent: December 25, 2001
    Assignee: Chiron Corporation
    Inventors: James G. Respess, Nicholas J. DePolo, Sunil Chada, Sybille Sauter, Mordechai Bodner, David A. Driver
  • Patent number: 6015686
    Abstract: The present invention provides compositions and methods for utilizing recombinant alphavirus vectors. Also disclosed are compositions and methods for making and utilizing eukaryotic layered vector initiation systems.
    Type: Grant
    Filed: March 15, 1995
    Date of Patent: January 18, 2000
    Assignee: Chiron Viagene, Inc.
    Inventors: Thomas W. Dubensky, Jr., John M. Polo, Douglas J. Jolly, David A. Driver
  • Patent number: 6013517
    Abstract: Retroviral vector constructs are described which have a 5' LTR, a tRNA binding site, a packaging signal, one or more heterologous sequences, an origin of second strand synthesis and a 3' LTR, wherein the vector construct lacks retroviral gag/pol or env coding sequences. In addition, gag/pol, and env expression-cassettes are described wherein the expression cassettes lack a consecutive sequence of more than 8 nucleotides in common. The above-described retroviral vector constructs, gag/pol and env expression cassettes may be utilized to construct producer cell lines which preclude the formation of replication competent virus.
    Type: Grant
    Filed: May 5, 1997
    Date of Patent: January 11, 2000
    Assignee: Chiron Corporation
    Inventors: James G. Respess, Nicholas J. DePolo, Sunil Chada, Sybille Sauter, Mordechai Bodner, David A. Driver
  • Patent number: 5843723
    Abstract: The present invention provides compositions and method,, for utilizing recombinant alphavirus vectors.
    Type: Grant
    Filed: October 30, 1996
    Date of Patent: December 1, 1998
    Assignee: Chiron Corporation
    Inventors: Thomas W. Dubensky, Jr., John M. Polo, Carlos E. Ibanez, Stephen M. W. Chang, Douglas J. Jolly, David A. Driver, Barbara A. Belli
  • Patent number: 5814482
    Abstract: The present invention provides compositions and methods for utilizing recombinant alphavirus vectors. Also disclosed are compositions and methods for making and utilizing eukaryotic layered vector initiation systems.
    Type: Grant
    Filed: October 30, 1996
    Date of Patent: September 29, 1998
    Inventors: Thomas W. Dubensky, Jr., John M. Polo, Douglas J. Jolly, David A. Driver
  • Patent number: 5789245
    Abstract: The present invention provides compositions and methods for utilizing recombinant alphavirus vectors. Also disclosed are compositions and methods for making and utilizing eukaryotic layered vector initiation systems.
    Type: Grant
    Filed: October 30, 1996
    Date of Patent: August 4, 1998
    Assignee: Chiron Corporation
    Inventors: Thomas W. Dubensky, Jr., John M. Polo, Carlos E. Ibanez, Stephen M. W. Chang, Douglas J. Jolly, David A. Driver